FI921134A0 - Oral antikoagulant- blodplaettinhibitorlaogdosformulering. - Google Patents

Oral antikoagulant- blodplaettinhibitorlaogdosformulering.

Info

Publication number
FI921134A0
FI921134A0 FI921134A FI921134A FI921134A0 FI 921134 A0 FI921134 A0 FI 921134A0 FI 921134 A FI921134 A FI 921134A FI 921134 A FI921134 A FI 921134A FI 921134 A0 FI921134 A0 FI 921134A0
Authority
FI
Finland
Prior art keywords
oral anticoagulant
blodplaettinhibitorlaogdosformulering
combination products
recurrent
preferrably
Prior art date
Application number
FI921134A
Other languages
English (en)
Finnish (fi)
Other versions
FI921134A (fi
Inventor
William Joseph Addicks
Joseph A Mollica
Gary Howard Slatko
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of FI921134A0 publication Critical patent/FI921134A0/fi
Publication of FI921134A publication Critical patent/FI921134A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FI921134A 1989-09-18 1992-03-17 Oral antikoagulant- blodplaettinhibitorlaogdosformulering. FI921134A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation
PCT/US1990/004950 WO1991004031A1 (fr) 1989-09-18 1990-09-05 Composition faiblement dosee d'anticoagulant oral/anti-agregants plaquettaires

Publications (2)

Publication Number Publication Date
FI921134A0 true FI921134A0 (fi) 1992-03-17
FI921134A FI921134A (fi) 1992-03-17

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921134A FI921134A (fi) 1989-09-18 1992-03-17 Oral antikoagulant- blodplaettinhibitorlaogdosformulering.

Country Status (22)

Country Link
US (1) US5041430A (fr)
EP (1) EP0493408B1 (fr)
JP (1) JPH05501109A (fr)
KR (1) KR950008307B1 (fr)
AT (1) ATE137972T1 (fr)
AU (1) AU635881B2 (fr)
CA (1) CA2065347A1 (fr)
CZ (1) CZ454090A3 (fr)
DE (1) DE69027036D1 (fr)
FI (1) FI921134A (fr)
GR (1) GR1001131B (fr)
HU (1) HUT62488A (fr)
IE (1) IE903356A1 (fr)
IL (1) IL95721A (fr)
LV (1) LV10050B (fr)
MA (1) MA21953A1 (fr)
MX (1) MX173727B (fr)
NO (1) NO920946D0 (fr)
NZ (1) NZ235337A (fr)
PT (1) PT95343B (fr)
WO (1) WO1991004031A1 (fr)
ZA (1) ZA907431B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (fr) * 1993-07-19 1998-02-03 Bernard Charles Sherman Composition pharmaceutique
EP0821587A4 (fr) * 1995-04-19 1999-05-19 Lipoprotein Technologies Inc Compositions, trousses et procedes d'administration d'antilipemiques et medicaments contre l'agregation plaquettaire
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
AU2002306461A1 (en) * 2001-03-28 2002-10-15 Rheologics, Inc. In vivo delivery methods and compositions
AU2003220022A1 (en) * 2002-03-01 2003-09-16 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
AU2004285436C1 (en) * 2003-10-20 2009-07-16 Teva Pharmaceutical Industries Ltd. Composition and dosage form for sustained effect of levodopa
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US7879352B2 (en) * 2004-05-21 2011-02-01 Accu-Break Technologies, Inc. Scored pharmaceutical tablets comprising a plurality of segments
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
US20100034878A1 (en) * 2006-12-19 2010-02-11 Bussey Henry I Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
WO2008156691A1 (fr) * 2007-06-19 2008-12-24 Duke University Anticoagulants en tant qu'agents anti-salissures
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
WO2012060847A1 (fr) 2010-11-07 2012-05-10 Targegen, Inc. Compositions et procédés de traitement de la myélofibrose
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ2012435A3 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (fr) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
EP0001503B1 (fr) * 1977-10-08 1981-01-07 Beecham Group Plc Compositions à effet antithrombotique contenant des benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
EP0169465B1 (fr) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Mélange de pyrimido-pyrimidines et d'acide O-acétyl-salicyclique, et/ou de leurs sels pharmacologiquement acceptables et son application

Also Published As

Publication number Publication date
GR1001131B (el) 1993-04-28
AU6330690A (en) 1991-04-18
PT95343B (pt) 1998-06-30
NZ235337A (en) 1993-05-26
EP0493408B1 (fr) 1996-05-15
NO920946L (no) 1992-03-11
DE69027036D1 (de) 1996-06-20
PT95343A (pt) 1991-08-14
IL95721A0 (en) 1991-06-30
EP0493408A4 (en) 1992-10-07
ZA907431B (en) 1992-05-27
KR920703046A (ko) 1992-12-17
HUT62488A (en) 1993-05-28
MX173727B (es) 1994-03-24
LV10050A (lv) 1994-05-10
IE903356A1 (en) 1991-04-10
EP0493408A1 (fr) 1992-07-08
NO920946D0 (no) 1992-03-11
LV10050B (en) 1995-02-20
WO1991004031A1 (fr) 1991-04-04
US5041430A (en) 1991-08-20
FI921134A (fi) 1992-03-17
JPH05501109A (ja) 1993-03-04
CZ454090A3 (en) 1996-11-13
GR900100702A (en) 1992-01-20
CA2065347A1 (fr) 1991-03-19
KR950008307B1 (ko) 1995-07-27
AU635881B2 (en) 1993-04-01
MA21953A1 (fr) 1991-04-01
ATE137972T1 (de) 1996-06-15
IL95721A (en) 1995-07-31

Similar Documents

Publication Publication Date Title
FI921134A0 (fi) Oral antikoagulant- blodplaettinhibitorlaogdosformulering.
BR9004553A (pt) Embalagem de sutura
DE69633680D1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE58903875D1 (de) Distyrylbiphenylverbindungen.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
NO894011D0 (no) Fremgangsmaate ved oksydering av alkaner.
DE69020554D1 (de) Verschleissfeste mehrschichtige gegenstände.
FI903178A0 (fi) Oeverdragen produkt.
DE59308079D1 (de) Doppelschubzentrifuge
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
DE69008713D1 (de) Produktangepasste verpackung.
DE69022695D1 (de) Phasenteileranordnung.
DE68917553D1 (de) Pyrogen adsorbierende Polymere.
FI902869A0 (fi) Vegetabel produkt.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
ES1010967Y (es) Etiqueta doble.
IT8835514V0 (it) Gioco di pronostici basato sulle quotazioni dei titoli azionari
ES1016142Y (es) Pequeno aparato electrodomestico para la elaboracion de comidas.
IT216152Z2 (it) Chiusura di stivale da motocross.
ES1011155Y (es) Colgador de doble percha.
AR240472Q (es) Un procedimiento para la preparaciond e una composicon lubricante de derivados carboxilicos.
FI882012A0 (fi) Ledstruktur foer en tippdoerr.